NIH study identifies promising COVID-19 treatments
Washington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 … Continue reading NIH study identifies promising COVID-19 treatments
Tesla to acquire German battery assembly maker
Palo Alto – Tesla Inc has agreed to acquire German ATW Automation, a supplier assembling battery modules and packs for the auto industry, a source familiar with the transaction said on Friday. ATW, a subsidiary of Canadian ATS Automation Tooling … Continue reading Tesla to acquire German battery assembly maker
Investigational COVID-19 vaccine well-tolerated
Washington – A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of … Continue reading Investigational COVID-19 vaccine well-tolerated
China approves U.S. wealth management company
BEIJING – China has approved a wealth management joint venture between U.S. asset manager BlackRock Inc, Singapore state investor Temasek Holdings (Pte) Ltd and China Construction Bank Corp (CCB), as China gradually opens up its financial sector to international firms. … Continue reading China approves U.S. wealth management company
NIH-Moderna COVID-19 vaccine shows promise
Washington – The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National … Continue reading NIH-Moderna COVID-19 vaccine shows promise